Objective To retrospectively review the clinical data from patients undergoing radical cystectomy for bladder cancer, and to analyse the complications and survival rates associated with this operation in a developing country. Patients and methods The study comprised 105 patients who underwent radical cystectomy from 1986 to 1993. Data were collected from retrospective reviews of hospital and physician's of®ce records, and by contact with the patients. Metastatic status was evaluated before surgery and tumours staged using the TumourNodes-Metastasis classi®cation. The indication for surgery was histologically con®rmed muscle invasion after transurethral resection biopsy, or endoscopically uncontrollable super®cial disease. The data were analysed to assess the perioperative complications and long-term survival, with 5-year survival rates determined using Kaplan±Meier survival curves. Results The complication rate was 27.6%; most of the complications were managed conservatively with good results and re-operation was required in only two patients. There were two deaths (1.9%) at 15±45 days after surgery, but none during surgery. Patients were divided into node-negative and node-positive groups for analysis and 5-year survival rates determined; for node-negative organ-con®ned disease (fpT3A) the survival was 68% and for nonorgan-con®ned disease (opT3B) 25%. The 5-year survival rate in the presence of nodal metastases was 13% for N1 and none for N2 disease. Six patients developed urethral recurrence, detected on follow-up urethral-wash cytology. Five of these patients underwent urethrectomy, and four of the six survived for 5 years. Pelvic recurrence occurred in ®ve patients (4.7%), none of whom survived for 5 years. Conclusion Radical cystectomy and pelvic lymph node dissection remains the mainstay of treatment in muscle-invasive bladder cancer. This is a relatively safe procedure with minimal morbidity and mortality; 68% of the present patients with organ-con®ned disease survived 5 years and 12 patients were alive at 10 years, indicating the effectiveness of this operation in selected cases. However, <29% of patients with nonorgan-con®ned and nodal metastatic disease survived 5 years, thereby implying the need for more effective adjuvant therapy in these patients. Radical cystectomy is a viable option in developing countries, with 5-year survival rates comparable with most large published series.